MedTrace Logo

Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis

NCT05560841 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-10-04

No results posted yet for this study

Summary

Evaluate the effectiveness of Nailner Brush 2-in-1 in the treatment of onychomycosis based on the blinded evaluation of the percentage of healthy nail surface after 6 months of treatment compared to baseline.

Conditions

  • Onychomycosis

Interventions

DEVICE

topical treatment

Topical application of Nailner brush 2in1 for toenail onychomycosis

Sponsors & Collaborators

  • Karo Pharma AB

    lead INDUSTRY

Principal Investigators

  • Pr. Nejib DOSS, MD · Dermascan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-28
Primary Completion
2023-01-12
Completion
2023-04-10

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05560841 on ClinicalTrials.gov